Literature DB >> 19817339

Diagnosis and management of dehydration in children.

Amy Canavan1, Billy S Arant.   

Abstract

The most useful individual signs for identifying dehydration in children are prolonged capillary refill time, abnormal skin turgor, and abnormal respiratory pattern. However, clinical dehydration scales based on a combination of physical examination findings are better predictors than individual signs. Oral rehydration therapy is the preferred treatment of mild to moderate dehydration caused by diarrhea in children. Appropriate oral rehydration therapy is as effective as intravenous fluid in managing fluid and electrolyte losses and has many advantages. Goals of oral rehydration therapy are restoration of circulating blood volume, restoration of interstitial fluid volume, and maintenance of rehydration. When rehydration is achieved, a normal age-appropriate diet should be initiated.

Entities:  

Mesh:

Year:  2009        PMID: 19817339

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.

Authors:  Justin P Reinert; O'Neill Niyamugabo; Kiersi S Harmon; Norman E Fenn
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  Performance of clinical signs in the diagnosis of dehydration in children with acute gastroenteritis.

Authors:  Teuta Hoxha; Luan Xhelili; Mehmedali Azemi; Muharrem Avdiu; Vlora Ismaili-Jaha; Urata Efendija-Beqa; Violeta Grajcevci-Uka
Journal:  Med Arch       Date:  2015-02-21

3.  Point-of-Admission Serum Electrolyte Profile of Children less than Five Years Old with Dehydration due to Acute Diarrhoea.

Authors:  Matthias Mariere Okposio; Alphonsus Ndidi Onyiriuka; Blessing Imuetiyan Abhulimhen-Iyoha
Journal:  Trop Med Health       Date:  2015-10-03

4.  Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice.

Authors:  Suzanne J Faber; Nynke D Scherpbier; Hans J G Peters; Annemarie A Uijen
Journal:  BMC Nephrol       Date:  2019-12-04       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.